The Post and Courier recently published a feature on Dr. Robert Ryan and the groundbreaking work happening at Paradigm Therapeutics. The article explores the journey behind SD-101, a topical therapy showing promise for patients with Epidermolysis Bullosa (EB), and the personal story that continues to drive the company’s mission forward.